Compounds > almagate
Page last updated: 2024-08-25

almagate and Central Serous Retinopathy

almagate has been researched along with Central Serous Retinopathy in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arevalo, JF; Espinoza, JV1

Other Studies

1 other study(ies) available for almagate and Central Serous Retinopathy

ArticleYear
Single-session combined photodynamic therapy with verteporfin and intravitreal anti-vascular endothelial growth factor therapy for chronic central serous chorioretinopathy: a pilot study at 12-month follow-up.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2011, Volume: 249, Issue:8

    Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Central Serous Chorioretinopathy; Chronic Disease; Combined Modality Therapy; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Intravitreal Injections; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Porphyrins; Retrospective Studies; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Verteporfin; Visual Acuity

2011